Targeting synuclein-γ to counteract drug resistance in cancer

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.12, Iss.1, 2008-01, pp. : 59-68

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting 5-Lipoxygenase Signaling Pathways to Reverse Drug Resistance in Cancer

Letters in Drug Design & Discovery, Vol. 3, Iss. 7, 2006-09 ,pp. : 459-461

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting the Akt Kinase to Modulate Survival, Invasiveness and Drug Resistance of Cancer Cells

Current Medicinal Chemistry, Vol. 20, Iss. 15, 2013-05 ,pp. : 1923-1945

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Calmodulin in Reversing Multi Drug Resistance in Cancer Cells

Mini Reviews in Medicinal Chemistry, Vol. 6, Iss. 12, 2006-12 ,pp. : 1383-1389

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting AMPK Signaling Pathway to Overcome Drug Resistance for Cancer Therapy

Current Drug Targets, Vol. 17, Iss. 8, 2016-06 ,pp. : 853-864

Bentham Science Publishers

Access to resources Recommend Favorite

Tumor-Targeting Peptides and Small Molecules as Anti-Cancer Agents to Overcome Drug Resistance

Current Medicinal Chemistry, Vol. 21, Iss. 14, 2014-01 ,pp. : 1618-1630

Bentham Science Publishers

Access to resources Recommend Favorite